Nicotinamide in dermatology

References

• Gehring W. Nicotinic acid/niacinamide and the skin. J. Cosmet. Dermatol.3(2), 88–93 (2004).
   PubMedGoogle Scholar
• Damian D, Patterson C, Stapelberg M et al. UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J. Invest. Dermatol.128 (2), 447–454 (2008).
   PubMed Web of Science ®Google Scholar
• Yiasemides E, Sivapirabu G, Halliday GM et al. Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans. Carcinogenesis30(1), 101–105 (2009).
   PubMed Web of Science ®Google Scholar
• Niggli HJ, Rothlisberger R. Cyclobutane-type pyrimidine photodimer formation and induction of ornithine decarboxylase in human skin fibroblasts after UV irradiation. J. Invest. Dermatol.91(6), 579–584 (1988).
   PubMed Web of Science ®Google Scholar
• Keyse S, Tyrrell R. Induction of the heme oxygenase gene in human skin fibroblasts by hydrogen peroxide and UVA (365 nm) radiation; evidence for the involvement of the hydroxyl radical. Carcinogenesis11(5), 787–791 (1990).
   PubMed Web of Science ®Google Scholar
• Hersey P, Bradley M, Hasic E et al. Immunological effects of solarium exposure. Lancet1(8324), 545–548 (1983).
   PubMed Web of Science ®Google Scholar
• Kelly DA, Young AR, McGregor JM et al. Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J. Exp. Med.191(3), 561–566 (2000).
   PubMed Web of Science ®Google Scholar
• Fisher M, Kripke M. Systemic alteration induced in mice by ultraviolet irradiation and its relationship to ultraviolet carcinogenesis. Proc. Natl Acad. Sci. USA74(4), 1688–1690 (1977).
   PubMed Web of Science ®Google Scholar
• De Fabo EC, Kripke ML. Dose–response characteristics of immunologic unresponsiveness to UV-induced tumors produced by the UV irradiation of mice. Photochem. Photobiol.30(3), 385–390 (1979).
   PubMed Web of Science ®Google Scholar
• De Fabo EC, Kripke ML. Wavelength dependence and dose-rate independence of UV radiation induced suppression of immunologic unresponsiveness of mice to a UV-induced fibrosarcoma. Photochem. Photobiol.32, 183–188 (1980).
   PubMed Web of Science ®Google Scholar
• Marshall V. Premalignant and malignant skin tumours in immunosuppressed patients. Transplantation17(3), 272–275 (1974).
   PubMed Web of Science ®Google Scholar
• Noonan FP, Muller HK, Fears TR et al. Mice with genetically determined high susceptibility to ultraviolet (UV)-induced immunosuppression show enhanced UV carcinogenesis. J. Invest. Dermatol.121(5), 1176–1181 (2003).
   Google Scholar
• Streilein JW, Taylor JR, Vincek V et al. Relationship between ultraviolet radiation-induced immunosuppression and carcinogenesis. J. Invest. Dermatol.103(5 Suppl.), 107S–111S (1994).
   PubMed Web of Science ®Google Scholar
• Friedmann AC, Halliday GM, Barnetson RS et al. The topical isoflavonoid NV-07a reduces solar-stimualated UV-induced suppression of Mantoux reactions in humans. Photochem. Photobiol.80(3), 416–421 (2004).
   PubMed Web of Science ®Google Scholar
• Gensler HL. Prevention of immunosuppression and photocarcinogenesis by topical nicotinamide. Nutr. Cancer29(2), 157–162 (1997).
   PubMed Web of Science ®Google Scholar
• Gensler HL, Williams T, Huang AC et al. Oral niacin prevents photocarcinogensis and photoimunosuppression in mice. Nutr. Cancer34(1), 36–41 (1999).
   PubMed Web of Science ®Google Scholar
• Virag L, Szabo C. The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacol. Rev.54(3), 375–429 (2002).
   PubMed Web of Science ®Google Scholar
• Kosmadeki MG, Gilchrest BA. The role of telomeres in skin aging/photoaging. Micron35(3), 155–159 (2004).
   PubMed Web of Science ®Google Scholar
• Sivapirabu G, Yiasemides E, Halliday GM, Park J, Damian DL. Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans. Br. J. Dermatol.161(6), 1357–1364 (2009).
   PubMed Web of Science ®Google Scholar
• Poon TS, Barnetson RS, Halliday GM. Prevention of immunosuppression by sunscreens in humans is unrelated to protection from erythema and dependent on protection from ultraviolet A in the face of constant ultraviolet B protection. J. Invest. Dermatol.121(1), 184–190 (2003).
   PubMed Web of Science ®Google Scholar
• Katiyar SK. UV-induced immune suppression and photocarcinogenesis: chemoprevention by dietary botanical agents. Cancer Lett.255(1), 1–11(2007).
   PubMed Web of Science ®Google Scholar
• Sharma SD, Katiyar SK. Dietary grape-seed proanthocyanidin inhibition of ultraviolet B-induced immune suppression is associated with induction of IL-12. Carcinogenesis27(1), 95–102 (2006).
   PubMed Web of Science ®Google Scholar
• Moison RM, Beijersbergen Van Henegouwen GM. Dietary eicosapentanoic acid prevents systemic immunosuppression in mice induced by UVB radiation. Radiat Res.156, 36–44 (2001).
   PubMed Web of Science ®Google Scholar
• Kohler IK, Lorincz AL. Erythema elevatum diutinum treated with niacinamide and tetracycline. Arch Dermatol.116(6), 693–695 (1980).
   PubMedGoogle Scholar
• Chaffins ML, Collison D, Fivenson DP. Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases. J. Am. Acad. Dermatol.28(6), 998–1000 (1993).
   PubMed Web of Science ®Google Scholar
• Reiche L, Wojnarowska F, Mallon E. Combination therapy with nicotinamide and tetracyclines for cicatricial pemphigoid: further support for its efficacy. Clin. Exp. Dermatol.23(6), 254–257 (1998).
   PubMed Web of Science ®Google Scholar
• Chaidemenos GC. Tetracycline and nicotinamide in the treatment of blistering skin diseases. Clin. Dermatol.19(6), 781–785 (2001).
   PubMed Web of Science ®Google Scholar
• Fivenson DP, Kimbrough TL. Lichen planus pemphigoides: combination therapy with tetracycline and nicotinamide. J. Am. Acad. Dermatol.36(4), 638–640 (1997).
   PubMed Web of Science ®Google Scholar
• Kolbach DN, Remme JJ, Bos WH. Bullous pemphigoid successfully controlled by tetracycline and nicotinamide. Br. J. Dermatol.133(1), 88–90 (1995).
   PubMed Web of Science ®Google Scholar
• Namazi MR. Nicotinamide: a potential addition to the antipsoriatic weaponry. FASEB J.17(11), 1377–1379 (2003).
   PubMed Web of Science ®Google Scholar
• Bissett DL, Oblong JE, Berge CA. Niacinamide: a B vitamin that improves aging facial skin appearance. Dermatol. Surg.31(7 Pt 2), 860–865 (2005).
   PubMed Web of Science ®Google Scholar
• Vlassara H. Recent progresson the biologic and clinical significance of advanced glycosylation end products. J. Lab. Clin. Med.124(1), 19–30 (1994).
   PubMed Web of Science ®Google Scholar
• Wu JT. Advanced glycosylation end products: a new disease marker for diabetes and aging. J. Clin. Lab. Anal.7(10), 252–255 (1993).
   PubMed Web of Science ®Google Scholar
• Wolff SP, Jiang ZY, Hung JV. Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic. Biol. Med.10(3), 339–352 (1991).
   PubMed Web of Science ®Google Scholar
• Dyer DG, Dunn JA, Thorpe SR et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest.91(6), 2463–2469 (1993).
   PubMed Web of Science ®Google Scholar
• Odetti P, Pronzato MA, Noberasco G et al. Relationships between glycation and oxidation related fluorescence in rat collagen during aging. Lab. Invest.70(1), 61–67 (1994).
   PubMed Web of Science ®Google Scholar
• Reber F, Geffarth R, Kasper M et al. Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection. Graefes Arch. Clin. Exp. Ophthalmol.241(3), 213–215 (2003).
   PubMed Web of Science ®Google Scholar
• Thornalley PJ. Glycation in diabetic neuropathy: characteristics consequences, causes, and therapeutic options. Int. Rev. Neurobiol.50, 37–57 (2002).
   PubMed Web of Science ®Google Scholar
• Matts PJ, Oblong JE, Bissett DL. A review of the range of effects of niacinamide in human skin. Int. Fed. Soc. Cosmet. Chem. Mag.24(Suppl. 5), 285–289 (2002).
   Google Scholar
• Varani J, Fisher GJ, Kang S et al. Molecular mechanisms of intrinsic skin aging and retinoid-induced repair and reversal. J. Invest. Dermatol. Symp. Proc.3(1), 57–60 (1998).
   PubMedGoogle Scholar
• Kang S, Duell EA, Fisher GJ et al. Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels of irritation. J. Invest. Dermatol.105(4), 549–556 (1995).
   PubMed Web of Science ®Google Scholar
• Kligman AM, Baker TJ, Gordan HL. Long-term histologic follow-up of phenol face peels. Plast. Reconstr. Surg.75(5), 652–659 (1975).
   Google Scholar
• Hannon DP. Wrinkle effacement by chemical peel. Poster presentation at: Meeting of the American Academy of Dermatology, Dallas, TX, USA, December 1991.
   Google Scholar
• Schwartz E, Kligman LH. Topical tretinoin increases the tropoelastin and fibronectin content of photoaged hairless mouse skin. J. Invest. Dermatol.104(4), 518–522 (1995).
   PubMed Web of Science ®Google Scholar
• Gebicki J, Sysa-Jedrzejowska A, Adamus J et al. 1-Methylnicotinamide, a potent anti-inflammatory agent of vitamin origin. Pol. J. Pharmacol.44(1), 109–112 (2003).
   Google Scholar
• Wozniacka M, Wiecorkowska M, Gebicki J, Sysa-Jedrzejowska A. Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. Clin. Exp. Dermatol.30(6), 632–635 (2005).
   PubMed Web of Science ®Google Scholar
• Draelos ZD, Matsubara A, Smiles K. The effect of 2% niacinamide on facial sebum production. J. Cosmet. Laser Ther.8(2), 96–101 (2006).
   PubMedGoogle Scholar
• Jacobsen EL, Kim H, Kim M et al. A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin. Exp. Dermatol.16(6), 490–499 (2007).
   PubMed Web of Science ®Google Scholar
• Ungerstedt JS, Blomback M, Soderstrom T. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin. Exp. Immunol.131(1), 48–52 (2003).
   PubMed Web of Science ®Google Scholar
• Rawlings AV, Matts PJ. Stratum corneum at the molecular level: an updated in relation to the dry skin cycle. J. Invest. Dermatol.124(6), 1099–1110 (2005).
   PubMed Web of Science ®Google Scholar
• Draelos ZD, Ertel K, Hartwig P et al. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis76(2), 135–141 (2005).
   PubMed Web of Science ®Google Scholar
• Hakozaki T, Minwalla L, Zhuang J et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br. J. Dermatol.147(1), 20–31 (2002).
   PubMed Web of Science ®Google Scholar
• Dunstan RW, Kennis RA. Selected heritable diseases of domesticated animals. In: Handbook of mouse mutations with skin and hair abnormalities. Sundberg JP (Ed.). CRC Press, Boca Raton, FL, USA, 509–532 (1994).
   Google Scholar